Centauri Health Solutions Acquires MedAllies, Broadens Health Data Network to Support Mission Critical Use Cases
PHOENIX--(BUSINESS WIRE)--Centauri Health Solutions ('Centauri'), a Phoenix, Arizona-based health information technology company, announced its acquisition of MedAllies, a New York-based Health Information Service Provider (HISP) and Qualified Health Information Network® (QHIN™) focused on health data connectivity and clinical data exchange.
'The addition of MedAllies strengthens our commitment to intelligently deliver clinical data solutions in a manner and form that facilitates value creation and empowers shared risk initiatives." - Mike McNelis, Centauri Co-Founder and CEO
A trailblazer in healthcare interoperability, MedAllies serves more than 1,000 hospitals/health systems, 5,000 ambulatory organizations, and 125,000 healthcare providers, ensuring the secure and seamless transmission of critical health information through national networks. This acquisition boosts Centauri's solutions with industry-leading integration, messaging, and record location services, enhancing access to care and financial support for patients, especially the most vulnerable.
'Centauri is the perfect partner for MedAllies. Our shared vision for interoperability and bi-directional exchange is essential to advancing healthcare,' said Dr. John Blair, CEO of MedAllies. 'We are excited to offer our clients the broadest clinical exchange network to support mission critical use cases.'
Mike McNelis, Centauri co-founder and CEO, added, 'The addition of MedAllies strengthens our commitment to intelligently deliver clinical data solutions in a manner and form that facilitates value creation and empowers shared risk initiatives. Connecting the MedAllies HISP and best-in-class Care Enabled Network/QHIN with Centauri's network and AI solutions offers significant value to all our clients.'
The acquisition was supported by Centauri's lead investor, Abry Partners, along with Silversmith Capital Partners and SV Health Investors. Santander served as the financial advisor to MedAllies with HunterMaclean as legal counsel. Kirkland and Ellis was legal counsel to Centauri for the transaction.
About Centauri Health Solutions
Centauri Health Solutions offers technology-enabled solutions to health systems and health plans for various healthcare programs including Medicare, Medicaid, Commercial and Exchange. Through collaboration with clients, we improve the lives and health outcomes of patients and members through compassionate outreach, sophisticated analytics, and intelligent clinical data delivery. Centauri addresses market issues such as uncompensated care in health systems; risk-adjusted revenue for specialized populations; and enhances access to and quality of care measurement. Headquartered in Phoenix, Arizona, Centauri Health Solutions employs 1,500 associates nationwide. Centauri has been listed on the Inc. 5000 from 2019-2022, and the 2020 Deloitte Technology Fast 500™ list. More details can be found at www.centaurihs.com.
About Abry Partners
Abry Partners is one of the most experienced and successful sector-focused private equity investment firms in North America. Since its founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5.0 billion of capital across its active funds. For more information about Abry Partners, visit www.abry.com.
About Silversmith Capital Partners
Founded in 2015, Silversmith Capital Partners is a Boston-based growth equity firm with $3.3 billion of capital under management. Silversmith's mission is to partner with and support the best entrepreneurs in growing, profitable technology and healthcare companies. Representative investments include ActiveCampaign, Appfire, Apryse, DistroKid, impact.com, Iodine Software, LifeStance Health, Onbe, and Webflow. For more information, including a full list of portfolio investments, visit www.silversmith.com or follow the firm on LinkedIn.
About SV Health Investors
SV Health Investors ('SV') is a private equity firm dedicated to investments in the healthcare and life sciences sector. Founded in 1993, with offices in Boston and London, SV manages >$2.0 billion across multiple investment strategies. SV's dedicated healthcare growth-buyout strategy seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies across outsourced services, life sciences and medical products, tech-enabled healthcare services, and healthcare information technology. Over the past 30+ years, SV has invested in 250+ healthcare companies. For more information about SV, visit www.svhealthinvestors.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
41 minutes ago
- Newsweek
Donald Trump Calls Green Tax Credits in 'Big Beautiful Bill' 'Scam'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump criticized his own federal budget legislation in a post on Truth Social Saturday. "I HATE 'GREEN TAX CREDITS' IN THE GREAT, BIG, BEAUTIFUL BILL," the president said, adding "They are largely a giant SCAM." The bill, which includes $4.9 trillion package packed with tax breaks, budget cuts and new Medicaid work requirements, made it past the House last month in a close 215-214 vote, with two Republicans breaking ranks to vote "no," Newsweek previously reported. The next hurdle, opposition and infighting in the Senate. Now, Trump has stated even he has problems with outlined initiatives. "I would much prefer that this money be used somewhere else, including reductions. 'Anywhere' would be preferable!" Trump exclaimed. "Windmills, and the rest of this "JUNK," are the most expensive and inefficient energy in the world, is destroying the beauty of the environment, and is 10 times more costly than any other energy," the President explained, adding "None of it works without massive government subsidy (energy should NOT NEED SUBSIDY!). Also, it is almost exclusively made in China!!! It is time to break away, finally, from this craziness!!!" This is a breaking news story. Updates to come.
Yahoo
an hour ago
- Yahoo
Dan Ives Says Market Is 'Massively Underestimating' This AI Play, Urges Investors To Look Beyong Mag 7
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Dan Ives' new artificial intelligence exchange-traded fund (ETF) holds securities beyond the Magnificent 7 stocks, as he believes in looking past valuations for investments in the technology sector. What Happened: The Dan IVES Wedbush AI Revolution ETF (NYSE:IVES), managed by the Wedbush analyst, started trading on June 4, earlier this month. Ives boasts of the fund by saying that it just doesn't have the top four, five Magnificent 7 names, but stocks which investors wouldn't even thematically consider as an AI name today. "I believe the market is still massively underestimating what the growth is going to look like for the AI revolution in tech," he told CNBC. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — According to him, tech trade remains significant even for the investors who missed out on its growth in the past few years. "If you focus just on valuation, you miss every transformational tech stock of the last 20 years," Ives said. Ives says Oracle Corp. (NYSE:ORCL) will be the 'epicenter' of the AI theme, while highlighting other 'AI 30' stocks which are part of his fund. Palantir Technologies Inc. (NASDAQ:PLTR), International Business Machines Corp. (NYSE:IBM), Salesforce Inc. (NYSE:CRM), SoundHound AI Inc. (NASDAQ:SOUN), and Innodata Inc. (NASDAQ:INOD) are a few notable names that are a part of his ETF's 'AI 30' basket. Microsoft Corp. (NASDAQ:MSFT), Nvidia Corp. (NASDAQ:NVDA), and Broadcom Inc. (NASDAQ:AVGO) are the top three holdings of the IVES It Matters: The 'AI 30' stocks, which are a part of the IVES ETF, hold the AI plays from multiple industries. They include hyperscalers, cybersecurity, consumer platforms, and robotics. According to Ives, the list was compiled from his deep dives into major AI players. The ETF has $183 million in assets under management as of June 17 close. Ives said that the AI space was experiencing a "golden age." The Dan IVES Wedbush AI Revolution ETF has risen by 2.76% since its inception. A comparable index, S&P Kensho Global Artificial Intelligence Enablers, rose 6.08% on a month-to-date basis. Meanwhile, the SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 index and Nasdaq 100 index, respectively, declined slightly on Wednesday. The SPY was down 0.015% at $597.44, while the QQQ was 0.017% lower at $528.99, according to Benzinga Pro data. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Shutterstock This article Dan Ives Says Market Is 'Massively Underestimating' This AI Play, Urges Investors To Look Beyong Mag 7 originally appeared on
Yahoo
an hour ago
- Yahoo
Oscar Health (OSCR) Soars 13% on Fourth Straight Day, Here's Why
Oscar Health, Inc. (NYSE:OSCR) is one of the Oscar Health extended its winning streak to a fourth consecutive day on Friday, jumping 13.05 percent to close at $21.22 apiece as investor sentiment was influenced by the previous days' surge. During the shortened, four-day trading week, shares of Oscar Health, Inc. (NYSE:OSCR) already grew by 52 percent, with analysts pointing to meme trading as having buoyed its share prices. Additionally, investor sentiment was supported by a new proposal for Medicare that would allow individuals and employers to enroll in a new version called 'Part E.' A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While this would heighten competition with private insurers such as Oscar Health, Inc. (NYSE:OSCR), the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
